These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38342578)

  • 21. Tinea capitis: epidemiology, diagnosis, treatment, and control.
    Frieden IJ; Howard R
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S42-6. PubMed ID: 8077507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tinea capitis: clinical features and therapeutic alternatives].
    Messina F; Walker L; Romero MLM; Arechavala AI; Negroni R; Depardo R; Marin E; Santiso GM
    Rev Argent Microbiol; 2021; 53(4):309-313. PubMed ID: 33618899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of scalp ringworm.
    Drug Ther Bull; 1996 Jan; 34(1):5-6. PubMed ID: 8746192
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.
    Cáceres-Ríos H; Rueda M; Ballona R; Bustamante B
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):80-4. PubMed ID: 10607324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric tinea capitis caused by Trichophyton violaceum and Trichophyton soudanense in Rochester, Minnesota, United States.
    Grigoryan KV; Tollefson MM; Olson MA; Newman CC
    Int J Dermatol; 2019 Aug; 58(8):912-915. PubMed ID: 30548845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tinea capitis.
    Gupta AK; Summerbell RC
    Med Mycol; 2000 Aug; 38(4):255-87. PubMed ID: 10975696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in Western China.
    Deng S; Hu H; Abliz P; Wan Z; Wang A; Cheng W; Li R
    Mycopathologia; 2011 Nov; 172(5):365-72. PubMed ID: 21701791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tinea in Tots: Cases and Literature Review of Oral Antifungal Treatment of Tinea Capitis in Children under 2 Years of Age.
    Zampella JG; Kwatra SG; Blanck J; Cohen B
    J Pediatr; 2017 Apr; 183():12-18.e3. PubMed ID: 28088394
    [No Abstract]   [Full Text] [Related]  

  • 31. Microsporum canis infections in children: results of a new oral antifungal therapy.
    Ginter G
    Mycoses; 1996; 39(7-8):265-9. PubMed ID: 9009643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tinea capitis: a current perspective.
    Elewski BE
    J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):1-20; quiz 21-4. PubMed ID: 10607315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
    Grover C; Arora P; Manchanda V
    Int J Dermatol; 2012 Apr; 51(4):455-8. PubMed ID: 22435438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
    Friedlander SF
    Pediatr Infect Dis J; 1999 Feb; 18(2):205-10. PubMed ID: 10048703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal-Onset Inflammatory Tinea Capitis by Microsporum canis Due to a Woolen Hat.
    Zou X; Chen W; Li R
    Mycopathologia; 2023 Oct; 188(5):585-587. PubMed ID: 36646941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach.
    Kassem R; Shemesh Y; Nitzan O; Azrad M; Peretz A
    BMC Pediatr; 2021 Aug; 21(1):363. PubMed ID: 34445992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing tinea capitis prevalence in Stockholm reflects immigration.
    Hällgren J; Petrini B; Wahlgren CF
    Med Mycol; 2004 Dec; 42(6):505-9. PubMed ID: 15682638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of tinea capitis. A status report.
    Del Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():38-45. PubMed ID: 10492665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Griseofulvin versus terbinafine in the treatment of tinea capitis: a meta-analysis of randomized, clinical trials.
    Fleece D; Gaughan JP; Aronoff SC
    Pediatrics; 2004 Nov; 114(5):1312-5. PubMed ID: 15520113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.